Latest filing published 30 Oct 2024 for BeOne Medicines Ltd..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Glazer Donald Wayne is a Director of BeOne Medicines Ltd., the only issuer in 29 filings published from August 22, 2018 to October 30, 2024. The record is made up of 18 sales, 6 purchases and 5 filings of another kind. None of the purchases or sales carries a recorded amount, so only their number can be read: purchases are 25% of open-market trades.
The year 2019 is the busiest, with 9 filings; 2018 has 4, 2020 and 2021 have 5 each, 2022 and 2023 one each, and 2024 four. No filing falls in the last twelve months. The publication delay is 5 days at the median.
21, 19 and 19 trades by Wayne fall within 30 days of colleagues at BeOne Medicines Ltd., in that order. In the same direction: 16, 18 and 16. The colleagues, in the same order: Oyler John Victor, Wang Xiaodong and Jane Huang. By kind, the record holds 5 other filings, 6 purchases and 18 sales.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 29 declarations